Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Improving Maternal Nutrition in Matlab (IMNiM)

In-home, Intensive Nutrition Counseling to Improve Gestational Weight Gain in Rural Bangladesh: A Cluster-Randomized Controlled Trial

Background: Maternal undernutrition and inadequate gestational weight gain (GWG) are prevalent in rural communities of low- and middle-income countries (LMICs). In Matlab, Bangladesh, 54% of the women fail to gain adequate weight (>4 kg) in the third trimester. Risks associated with inadequate GWG include giving birth to a small-for-gestational age (SGA) infant, low birth weight (LBW) infant, preterm birth (PTB), etc. Few contemporary studies examined the efficacy of nutrition counseling on GWG improvement in LMICs.

Objectives: The primary objective of this study is to assess whether in-home, intensive nutrition counseling during pregnancy, compared to standard antenatal care, could improve GWG among pregnant women in rural Bangladesh.

Methods: This prospective, two-arm, parallel group, equal allocation, open-label, community-based, cluster-randomized controlled trial will be conducted in the icddr,b service area of Matlab, a rural subdistrict of Bangladesh. Clusters will be randomly allocated 1:1 to the intervention arm in which pregnant women will receive monthly in-home, intensive nutrition counseling or the control arm in which pregnant women will receive standard antenatal care as offered by icddr,b and Govt. facilities. Fixed Site Clinics (FSCs) located at the homes of the community health research workers (CHRWs) will act as clusters. Of the 33 FSCs serving rural areas in the icddr,b service area, 20 will be selected randomly and listed. These 20 clinics will then be randomly allocated 1:1 to either an intervention or control group using a computer-generated random allocation sequence. To fulfil the required sample size, each selected CHRW will enroll 16 consecutive pregnancies. Required sample size is 16 women per cluster i.e. 160 women per arm. Eligible participants will be enrolled upon obtaining their consent by 13 and 6/7 weeks of gestation (first trimester) and followed up to 6 weeks postpartum. Trained health workers will visit the homes of the women in the intervention arm once a month and provide nutrition counseling to the women and her influential family members such as mothers, mothers-in-law and husbands. Both intention-to-treat and per-protocol analyses will be performed.

Outcome measures/variables: Proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to the US Institute of Medicine (IOM) 2009 guidelines is the primary outcome variable.

Studieoversigt

Status

Aktiv, ikke rekrutterende

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

287

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Chandpur, Bangladesh
        • International Centre for Diarrhoeal Disease Research, Bangladesh

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 39 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Pregnant women permanently residing in the icddr,b service area of Matlab fulfilling the following criteria:

Inclusion Criteria:

  • aged 18-39 years
  • in the first trimester of pregnancy (before 14 weeks of gestation)
  • BMI 16-24.99 kg/m^2 measured on enrollment
  • willing to participate in the study

Exclusion criteria

  • multiple pregnancy (carrying two or more fetuses)
  • threatened abortion, persistent pervaginal bleeding, or cervical incompetence
  • history of three or more consecutive abortions
  • history of gestational diabetes, macrosomia, gestational hypertension, preeclampsia/eclampsia in a prior pregnancy
  • chronic diseases, such as hypertension, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, pancreatic diseases, Crohn's disease, ulcerative colitis, diabetes mellitus, thyroid dysfunction, immunological diseases, malignancy or any other diseases which could impede compliance with the study protocol
  • taking medications known to influence fetal growth, such as insulin, thyroid hormones, glucocorticoids
  • known case of serious psychiatric or behavioral disorders, such as schizophrenia, bipolar disorder
  • scored as moderate or worse on enrollment on any one of the subscales of the Depression, Anxiety and Stress Scales-21 (DASS-21)
  • inability to read or write Bengali
  • belonging to moderately or severely food insecure households as measured by the Household Food Insecurity Access Scale (HFIAS)
  • having a plan to move or deliver outside the study area
  • women practicing some form of vegetarianism
  • women belonging to a household from which another woman is already enrolled in the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention
In this arm, pregnant women, along with their influential family members such as mothers, mothers-in-law, and husbands, will receive monthly in-home, intensive nutrition counseling during the prenatal period.
  • Individualized sessions will be conducted by trained health workers following a standard document (counseling booklet)
  • The messages to be provided through the counseling will be contextualized
  • Sessions will start from the early second trimester and repeat monthly until 36 weeks of gestation
  • Counseling sessions will be conducted at the participant's place
  • Sessions will involve influential family members such as the husband, mother-in-law, mother, and the household head along with the pregnant women
  • Women will receive personalized feedback on their dietary intake pattern (dietary diversity) and the rate of weight gain in each session
  • Sessions will be tailored according to each participant's need and progress
Ingen indgriben: Control
Pregnant women in this arm will receive standard antenatal care.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to IOM 2009 guidelines
Tidsramme: Pre-delivery
Pregnancy trimesters are defined as follows: 1st trimester (0 weeks - 13+6 weeks), 2nd trimester (14 completed weeks - 27+6 weeks), and 3rd trimester (28 completed weeks - childbirth). Rate of weight gain between two time points (trimesters) will be calculated by subtracting the weight measured at the first time point from the weight measured at the second time point and dividing the derived value by the difference in weeks between the two time points.
Pre-delivery

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
total gestational weight gain (kg)
Tidsramme: pre-delivery
pre-delivery
rate of weight gain during the 2nd and 3rd trimester (kg/week)
Tidsramme: pre-delivery
pre-delivery
proportion of women with inadequate total GWG according to IOM criteria
Tidsramme: pre-delivery
pre-delivery
proportion of women with inadequate total GWG according to local criteria
Tidsramme: pre-delivery
pre-delivery
proportion of women with inadequate third trimester weight gain according to local criteria
Tidsramme: pre-delivery
pre-delivery
proportion of preterm births
Tidsramme: at delivery
childbirth before 37 completed weeks
at delivery
maternal mid-upper arm circumference (MUAC) (mm)
Tidsramme: baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
maternal weight (kg)
Tidsramme: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
maternal body mass index (BMI) (kg/m^2)
Tidsramme: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
weight and height (at baseline) will be combined to report BMI
baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
infant weight (g)
Tidsramme: at birth (delivery) and after 4 weeks
at birth (delivery) and after 4 weeks
infant length (cm)
Tidsramme: at birth (delivery) and after 4 weeks
at birth (delivery) and after 4 weeks
infant head circumference (cm)
Tidsramme: at birth (delivery) and after 4 weeks
at birth (delivery) and after 4 weeks
proportion of low birth weight (< 2500 g) infants
Tidsramme: at birth (delivery)
at birth (delivery)
proportion of small for gestational age (<10th percentile) infants according to Intergrowth-21st standards
Tidsramme: at birth (delivery)
at birth (delivery)
proportion of women with pregnancy complications e.g. anemia, preeclampsia
Tidsramme: at delivery
at delivery
proportion of women with obstetric complications e.g. induction of labor, caesarean section
Tidsramme: at delivery
at delivery
newborn Apgar score
Tidsramme: at birth (delivery)
at birth (delivery)
proportion of infants developing morbidity
Tidsramme: 4 weeks after birth
4 weeks after birth
proportion of infant mortality
Tidsramme: 4 weeks after birth
4 weeks after birth
dietary diversity score according to the "Guidelines for Measuring Household and Individual Dietary Diversity"
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
score range: 0-9; higher scores indicate a better outcome
baseline, 36 weeks of gestation and 6 weeks post-partum
dietary diversity score according to the "Minimum Dietary Diversity for Women: A Guide to Measurement"
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
score range: 0-10; higher scores indicate a better outcome
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with inadequate dietary diversity accroding to the "Minimum Dietary Diversity for Women: A Guide to Measurement"
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
score range: 0-10; <5 indicates inadequate dietary diversity
baseline, 36 weeks of gestation and 6 weeks post-partum
energy consumption (kcal)
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
baseline, 36 weeks of gestation and 6 weeks post-partum
protein consumption (g)
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of depression as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of anxiety as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
baseline, 36 weeks of gestation and 6 weeks post-partum
proportion of women with symptoms of stress as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Tidsramme: baseline, 36 weeks of gestation and 6 weeks post-partum
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms. Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
baseline, 36 weeks of gestation and 6 weeks post-partum
healthcare seeking and services utilization e.g. number of prenatal visits
Tidsramme: at delivery
at delivery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: S. M. Tafsir Hasan, MBBS, MS, Nutrition and Clinical Services Division, icddr,b

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

15. januar 2020

Primær færdiggørelse (Forventet)

30. september 2021

Studieafslutning (Forventet)

31. oktober 2021

Datoer for studieregistrering

Først indsendt

28. december 2019

Først indsendt, der opfyldte QC-kriterier

27. april 2021

Først opslået (Faktiske)

3. maj 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

3. maj 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. april 2021

Sidst verificeret

1. april 2021

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Svangerskabsforøgelse

Kliniske forsøg med In-home, intensive nutrition counseling

Abonner